Celltrion
068270.KS
#743
Rank
ยฃ23.98 B
Marketcap
ยฃ109.61
Share price
1.40%
Change (1 day)
16.99%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): ยฃ1.42

According to Celltrion 's latest financial reports the company's current EPS (TTM) is ยฃ1.40. In 2024 the company made an earnings per share (EPS) of ยฃ0.99 a decrease over its 2023 EPS that were of ยฃ1.96.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)ยฃ1.4243.03%
2024ยฃ0.99-49.57%
2023ยฃ1.96-2.08%
2022ยฃ2.01-11.72%
2021ยฃ2.272.03%
2020ยฃ2.2382.8%
2019ยฃ1.2218.31%
2018ยฃ1.03-36.33%
2017ยฃ1.62161.25%
2016ยฃ0.622.86%
2015ยฃ0.6017.84%
2014ยฃ0.515.87%
2013ยฃ0.48-70.85%
2012ยฃ1.66134.09%
2011ยฃ0.7143.59%
2010ยฃ0.4974.49%
2009ยฃ0.28317.8%
2008ยฃ0.06754-71.7%
2007ยฃ0.24